| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 76.03B | 76.08B | 64.10B | 52.69B | 86.93B | 77.39B |
| Gross Profit | 70.44B | 66.16B | 54.42B | 35.33B | 69.99B | 60.88B |
| EBITDA | 4.84B | 7.04B | 37.92B | 16.63B | 34.35B | 33.45B |
| Net Income | -5.68B | -5.83B | 12.51B | 3.39B | 13.02B | 14.35B |
Balance Sheet | ||||||
| Total Assets | 718.74B | 709.64B | 761.64B | 1.50T | 1.61T | 1.40T |
| Cash, Cash Equivalents and Short-Term Investments | 404.54B | 53.47B | 97.94B | 181.02B | 261.30B | 168.45B |
| Total Debt | 105.61B | 87.02B | 100.16B | 594.56B | 585.65B | 543.02B |
| Total Liabilities | 598.65B | 583.39B | 628.52B | 1.40T | 1.50T | 1.31T |
| Stockholders Equity | 117.99B | 123.98B | 131.71B | 99.64B | 104.29B | 89.57B |
Cash Flow | ||||||
| Free Cash Flow | -15.64B | 8.73B | 1.36B | -38.78B | 45.09B | -63.24B |
| Operating Cash Flow | -15.34B | 13.30B | 8.05B | -30.98B | 51.70B | -57.70B |
| Investing Cash Flow | -20.66B | -32.18B | -86.35B | -21.87B | -6.03B | -7.16B |
| Financing Cash Flow | -11.69B | -25.19B | -5.11B | -34.16B | 13.76B | 95.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥85.85B | 6.63 | ― | 5.75% | 10.85% | 30.77% | |
80 Outperform | ¥199.56B | 6.74 | ― | 4.01% | -2.39% | -4.54% | |
76 Outperform | ¥2.09T | 10.19 | 9.37% | 4.13% | -0.87% | 6.88% | |
74 Outperform | ¥245.23B | 12.14 | 14.00% | 5.13% | 3.27% | -1.81% | |
69 Neutral | ¥3.76T | 10.42 | 10.23% | 3.93% | -2.45% | 35.60% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
43 Neutral | ¥171.33B | 13.27 | 7.26% | 4.16% | 14.69% | -114.36% |